Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib

Respir Investig. 2019 May;57(3):290-291. doi: 10.1016/j.resinv.2019.02.001. Epub 2019 Feb 21.

Affiliations

¹ Department of Clinical Medical and Neurosciences, Respiratory Disease and Lung Transplantation Section, Le Scotte Hospital, University of Siena, Siena, Italy. Electronic address: laurabergantini@gmail.com.
² Department of Clinical Medical and Neurosciences, Respiratory Disease and Lung Transplantation Section, Le Scotte Hospital, University of Siena, Siena, Italy.

PMID: 30799155
DOI: 10.1016/j.resinv.2019.02.001

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Biomarkers / blood
Female
Humans
Idiopathic Pulmonary Fibrosis / diagnosis*
Idiopathic Pulmonary Fibrosis / drug therapy*
Idiopathic Pulmonary Fibrosis / physiopathology
Indoles / therapeutic use*
Male
Mucin-1 / blood*
Prognosis
Vital Capacity

Substances

Biomarkers
Indoles
MUC1 protein, human
Mucin-1
nintedanib